A detailed history of Cresset Asset Management, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 37,494 shares of CELC stock, worth $497,170. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,494
Previous 37,494 -0.0%
Holding current value
$497,170
Previous $614,000 8.96%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $267,674 - $394,487
18,984 Added 102.56%
37,494 $614,000
Q2 2023

Aug 14, 2023

BUY
$9.39 - $12.18 $49,644 - $64,395
5,287 Added 39.98%
18,510 $203,000
Q2 2022

Aug 15, 2022

BUY
$5.35 - $10.11 $70,743 - $133,684
13,223 New
13,223 $120,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $198M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.